Abstract
Influenza is a febrile respiratory disease, which is usually associated with a mild acute self-limited illness. However, certain risk factors, including ageing, are associated with severity of disease and the occurrence of influenza-related complications. Influenza infection has shown to be foremost among all infectious diseases in its association with an age-related increase in the incidence of serious complications. A decrease in immune function is a hallmark of ageing that imposes negative effects in its ability to resist influenza virus infection and its response to vaccination. It has been recognized that the ageing process affects both branches of the immune system, namely, the innate and adaptive immune systems.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Agrawal A, Agrawal S, Gupta S (2007) Dendritic cells in human aging. Exp Gerontol 42(5):421–426
Aspinall R, Henson S, Pido-Lopez J et al (2004) Interleukin-7: an interleukin for rejuvenating the immune system. Ann N Y Acad Sci 1019:116–122
Aydar Y, Balogh P, Tew JG et al (2002) Age-related depression of FDC accessory functions and CD21 ligand-mediated repair of co-stimulation. Eur J Immunol 32(10):2817–2826
Banchereau J, Steinman RM (1998) Dendritic cells and the control of immunity. Nature 392(6673):245–252
Barker WH, Borisute H, Cox C (1998) A study of the impact of influenza on the functional status of frail older people. Arch Intern Med 158(6):645–650
Behzad H, Huckriede AL, Haynes L et al (2012) GLA-SE, a synthetic toll-like receptor 4 agonist, enhances T-cell responses to influenza vaccine in older adults. J Infect Dis 205(3):466–473
Bender BS, Small PA Jr (1993) Heterotypic immune mice lose protection against influenza virus infection with senescence. J Infect Dis 168(4):873–880
Blasco MA, Funk W, Villeponteau B et al (1995) Functional characterization and developmental regulation of mouse telomerase RNA. Science 269(5228):1267–1270
Bleackley RC, Lobe CG, Duggan B et al (1988) The isolation and characterization of a family of serine protease genes expressed in activated cytotoxic T lymphocytes. Immunol Rev 103:5–19
Borrego F, Alonso MC, Galiani MD et al (1999) NK phenotypic markers and IL2 response in NK cells from elderly people. Exp Gerontol 34(2):253–265
Brown LK (1994) Respiratory dysfunction in Parkinson’s disease. Clin Chest Med 15(4):715–727
Butcher S, Chahel H, Lord JM (2000) Review article: ageing and the neutrophil: no appetite for killing? Immunology 100(4):411–416
Carrat F, Flahault A (2007) Influenza vaccine: the challenge of antigenic drift. Vaccine 25(39–40):6852–6862
Chatta GS, Andrews RG, Rodger E et al (1993) Hematopoietic progenitors and aging: alterations in granulocytic precursors and responsiveness to recombinant human G-CSF, GM-CSF, and IL-3. J Gerontol 48(5):M207–M212
Colonna-Romano G, Bulati M, Aquino A et al (2003) B cells in the aged: CD27, CD5, and CD40 expression. Mech Ageing Dev 124(4):389–393
Covinsky KE, Palmer RM, Fortinsky RH et al (2003) Loss of independence in activities of daily living in older adults hospitalized with medical illnesses: increased vulnerability with age. J Am Geriatr Soc 51(4):451–458
Deans GD, Stiver HG, McElhaney JE (2010) Influenza vaccines provide diminished protection but are cost-saving in older adults. J Intern Med 267(2):220–227
Demotz S, Grey HM, Sette A (1990) The minimal number of class II MHC-antigen complexes needed for T cell activation. Science 249(4972):1028–1030
Doherty PC, Topham DJ, Tripp RA et al (1997) Effector CD4+ and CD8+ T-cell mechanisms in the control of respiratory virus infections. Immunol Rev 159:105–117
Drinka PJ, Krause P, Nest L (2003) Clinical features of influenza a virus infection in older hospitalized persons. J Am Geriatr Soc 51(8):1184
Dumont FJ, Staruch MJ, Fischer P et al (1998) Inhibition of T cell activation by pharmacologic disruption of the MEK1/ERK MAP kinase or calcineurin signaling pathways results in differential modulation of cytokine production. J Immunol 160(6):2579–2589
Effros RB (2007) Role of T lymphocyte replicative senescence in vaccine efficacy. Vaccine 25(4):599–604
Effros RB, Doherty PC, Gerhard W et al (1977) Generation of both cross-reactive and virus-specific T-cell populations after immunization with serologically distinct influenza A viruses. J Exp Med 145(3):557–568
Effros RB, Dagarag M, Spaulding C et al (2005) The role of CD8+ T-cell replicative senescence in human aging. Immunol Rev 205:147–157
Evans SA, Watson L, Hawkins M et al (1995) Respiratory muscle strength in chronic heart failure. Thorax 50(6):625–628
Ewen C, Kane KP, Shostak I et al (2003) A novel cytotoxicity assay to evaluate antigen-specific CTL responses using a colorimetric substrate for Granzyme B. J Immunol Methods 276(1–2):89–101
Fadok VA, Bratton DL, Konowal A et al (1998) Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF. J Clin Invest 101(4):890–898
Falsey AR, Hennessey PA, Formica MA et al (2005) Respiratory syncytial virus infection in elderly and high-risk adults. N Engl J Med 352(17):1749–1759
Fiore AE, Shay DK, Broder K et al (2009) Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009. MMWR Recomm Rep 58(RR-8):1–52
Franceschi C, Bonafe M, Valensin S (2000) Human immunosenescence: the prevailing of innate immunity, the failing of clonotypic immunity, and the filling of immunological space. Vaccine 18(16):1717–1720
Frasca D, Landin AM, Lechner SC et al (2008) Aging down-regulates the transcription factor E2A, activation-induced cytidine deaminase, and Ig class switch in human B cells. J Immunol 180(8):5283–5290
Frasca D, Diaz A, Romero M et al (2011) Age effects on B cells and humoral immunity in humans. Ageing Res Rev 10(3):330–335
Fulop T Jr, Foris G, Worum I et al (1985) Age-dependent alterations of Fc gamma receptor-mediated effector functions of human polymorphonuclear leucocytes. Clin Exp Immunol 61(2):425–432
Gomez CR, Boehmer ED, Kovacs EJ (2005) The aging innate immune system. Curr Opin Immunol 17(5):457–462
Goronzy JJ, Weyand CM (2005) T cell development and receptor diversity during aging. Curr Opin Immunol 17(5):468–475
Goronzy JJ, Fulbright JW, Crowson CS et al (2001) Value of immunological markers in predicting responsiveness to influenza vaccination in elderly individuals. J Virol 75(24):12182–12187
Gorse GJ, O’Connor TZ, Newman FK et al (2004) Immunity to influenza in older adults with chronic obstructive pulmonary disease. J Infect Dis 190(1):11–19
Govaert TM, Thijs CT, Masurel N et al (1994) The efficacy of influenza vaccination in elderly individuals. A randomized double-blind placebo-controlled trial. JAMA 272(21):1661–1665
Granucci F, Zanoni I, Feau S et al (2003) Dendritic cell regulation of immune responses: a new role for interleukin 2 at the intersection of innate and adaptive immunity. EMBO J 22(11):2546–2551
Grolleau-Julius A, Harning EK, Abernathy LM et al (2008) Impaired dendritic cell function in aging leads to defective antitumor immunity. Cancer Res 68(15):6341–6349
Ito T, Gorman OT, Kawaoka Y et al (1991) Evolutionary analysis of the influenza A virus M gene with comparison of the M1 and M2 proteins. J Virol 65(10):5491–5498
Janssens JP, Krause KH (2004) Pneumonia in the very old. Lancet Infect Dis 4(2):112–124
Jenne DE, Tschopp J (1988) Granzymes, a family of serine proteases released from granules of cytolytic T lymphocytes upon T cell receptor stimulation. Immunol Rev 103:53–71
Kohler S, Wagner U, Pierer M et al (2005) Post-thymic in vivo proliferation of naive CD4+ T cells constrains the TCR repertoire in healthy human adults. Eur J Immunol 35(6):1987–1994
Kronenberg RS, Drage CW (1973) Attenuation of the ventilatory and heart rate responses to hypoxia and hypercapnia with aging in normal men. J Clin Invest 52(8):1812–1819
Lalvani A, Dong T, Ogg G et al (1997) Optimization of a peptide-based protocol employing IL-7 for in vitro restimulation of human cytotoxic T lymphocyte precursors. J Immunol Methods 210(1):65–77
Lazuardi L, Jenewein B, Wolf AM et al (2005) Age-related loss of naive T cells and dysregulation of T-cell/B-cell interactions in human lymph nodes. Immunology 114(1):37–43
Loeb M (2003) Pneumonia in older persons. Clin Infect Dis 37(10):1335–1339
Marcelin G, DuBois R, Rubrum A et al (2012) A contributing role for anti-neuraminidase antibodies on immunity to pandemic H1N1 2009 influenza A virus. PLoS One 6(10):26335
McElhaney JE (2005) The unmet need in the elderly: designing new influenza vaccines for older adults. Vaccine 23(Suppl 1):S10–S25
McElhaney JE (2008) Influenza vaccination in the elderly: seeking new correlates of protection and improved vaccines. Aging health 4(6):603–613
McElhaney JE (2009) Prevention of infectious diseases in older adults through immunization: the challenge of the senescent immune response. Expert Rev Vaccines 8(5):593–606
McElhaney JE (2011) Influenza vaccine responses in older adults. Ageing Res Rev 10(3):379–388
McElhaney JE, Dutz JP (2008) Better influenza vaccines for older people: what will it take? J Infect Dis 198(5):632–634
McElhaney JE, Effros RB (2009) Immunosenescence: what does it mean to health outcomes in older adults? Curr Opin Immunol 21(4):418–424
McElhaney JE, Gravenstein S, Upshaw CM et al (2001) Granzyme B: a marker of risk for influenza in institutionalized older adults. Vaccine 19(27):3744–3751
McElhaney JE, Xie D, Hager WD et al (2006) T cell responses are better correlates of vaccine protection in the elderly. J Immunol 176(10):6333–6339
McElhaney JE, Ewen C, Zhou X et al (2009) Granzyme B: correlates with protection and enhanced CTL response to influenza vaccination in older adults. Vaccine 27(18):2418–2425
McElhaney JE, Zhou X, Talbot HK et al (2012) The unmet need in the elderly: how immunosenescence, CMV infection, co-morbidities and frailty are a challenge for the development of more effective influenza vaccines. Vaccine 30(12):2060–2067
McKenna RW, Washington LT, Aquino DB et al (2001) Immunophenotypic analysis of hematogones (B-lymphocyte precursors) in 662 consecutive bone marrow specimens by 4-color flow cytometry. Blood 98(8):2498–2507
McMichael AJ, Gotch FM, Noble GR et al (1983) Cytotoxic T-cell immunity to influenza. N Engl J Med 309(1):13–17
Meyer KC, Ershler W, Rosenthal NS et al (1996) Immune dysregulation in the aging human lung. Am J Respir Crit Care Med 153(3):1072–1079
Miller C, Kelsoe G (1995) Ig VH hypermutation is absent in the germinal centers of aged mice. J Immunol 155(7):3377–3384
Miyaji C, Watanabe H, Toma H et al (2000) Functional alteration of granulocytes, NK cells, and natural killer T cells in centenarians. Hum Immunol 61(9):908–916
Molinari NA, Ortega-Sanchez IR, Messonnier ML et al (2007) The annual impact of seasonal influenza in the US: measuring disease burden and costs. Vaccine 25(27):5086–5096
Molling JW, Kolgen W, van der Vliet HJ et al (2005) Peripheral blood IFN-gamma-secreting Valpha24 + Vbeta11+ NKT cell numbers are decreased in cancer patients independent of tumor type or tumor load. Int J Cancer 116(1):87–93
Monto AS, Ansaldi F, Aspinall R et al (2009) Influenza control in the 21st century: optimizing protection of older adults. Vaccine 27(37):5043–5053
Mullooly JP, Bennett MD, Hornbrook MC et al (1994) Influenza vaccination programs for elderly persons: cost-effectiveness in a health maintenance organization. Ann Intern Med 121(12):947–952
Nichol KL, Margolis KL, Wuorenma J et al (1994) The efficacy and cost effectiveness of vaccination against influenza among elderly persons living in the community. N Engl J Med 331(12):778–784
Nomellini V, Gomez CR, Kovacs EJ (2008) Aging and impairment of innate immunity. Contrib Microbiol 15:188–205
Nordin J, Mullooly J, Poblete S et al (2001) Influenza vaccine effectiveness in preventing hospitalizations and deaths in persons 65 years or older in Minnesota, New York, and Oregon: data from 3 health plans. J Infect Dis 184(6):665–670
Pasternack MS, Eisen HN (1985) A novel serine esterase expressed by cytotoxic T lymphocytes. Nature 314(6013):743–745
Plackett TP, Boehmer ED, Faunce DE et al (2004) Aging and innate immune cells. J Leukoc Biol 76(2):291–299
Plowden J, Renshaw-Hoelscher M, Engleman C et al (2004) Innate immunity in aging: impact on macrophage function. Aging Cell 3(4):161–167
Reichert TA, Simonsen L, Sharma A et al (2004) Influenza and the winter increase in mortality in the United States, 1959–1999. Am J Epidemiol 160(5):492–502
Rimmelzwaan GF, McElhaney JE (2008) Correlates of protection: novel generations of influenza vaccines. Vaccine 26(Suppl 4):D41–D44
Rock KL, Shen L (2005) Cross-presentation: underlying mechanisms and role in immune surveillance. Immunol Rev 207:166–183
Rouvier E, Luciani MF, Golstein P (1993) Fas involvement in Ca(2+)-independent T cell-mediated cytotoxicity. J Exp Med 177(1):195–200
Sambhara S, McElhaney JE (2009) Immunosenescence and influenza vaccine efficacy. Curr Top Microbiol Immunol 333:413–429
Saurwein-Teissl M, Lung TL, Marx F et al (2002) Lack of antibody production following immunization in old age: association with CD8(+)CD28(−) T cell clonal expansions and an imbalance in the production of Th1 and Th2 cytokines. J Immunol 168(11):5893–5899
Shahid Z, Kleppinger A, Gentleman B et al (2010) Clinical and immunologic predictors of influenza illness among vaccinated older adults. Vaccine 28(38):6145–6151
Shi Y, Yamazaki T, Okubo Y et al (2005) Regulation of aged humoral immune defense against pneumococcal bacteria by IgM memory B cell. J Immunol 175(5):3262–3267
Skowronski DM, Hottes TS, McElhaney JE et al (2011) Immuno-epidemiologic correlates of pandemic H1N1 surveillance observations: higher antibody and lower cell-mediated immune responses with advanced age. J Infect Dis 203(2):158–167
Solana R, Mariani E (2000) NK and NK/T cells in human senescence. Vaccine 18(16):1613–1620
Solana R, Alonso MC, Pena J (1999) Natural killer cells in healthy aging. Exp Gerontol 34(3):435–443
Spaulding C, Guo W, Effros RB (1999) Resistance to apoptosis in human CD8+ T cells that reach replicative senescence after multiple rounds of antigen-specific proliferation. Exp Gerontol 34(5):633–644
Steger MM, Maczek C, Berger P et al (1996) Vaccination against tetanus in the elderly: do recommended vaccination strategies give sufficient protection. Lancet 348(9029):762
Thompson WW, Shay DK, Weintraub E et al (2003) Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA 289(2):179–186
Thompson WW, Shay DK, Weintraub E et al (2004) Influenza-associated hospitalizations in the United States. JAMA 292(11):1333–1340
Tolep K, Kelsen SG (1993) Effect of aging on respiratory skeletal muscles. Clin Chest Med 14(3):363–378
Turner DA, Wailoo AJ, Cooper NJ et al (2006) The cost-effectiveness of influenza vaccination of healthy adults 50–64 years of age. Vaccine 24(7):1035–1043
Vallejo AN (2005) CD28 extinction in human T cells: altered functions and the program of T-cell senescence. Immunol Rev 205:158–169
Van der Sluijs KF, van Elden LJ, Nijhuis M et al (2004) IL-10 is an important mediator of the enhanced susceptibility to pneumococcal pneumonia after influenza infection. J Immunol 172(12):7603–7609
Vescovini R, Biasini C, Fagnoni FF et al (2007) Massive load of functional effector CD4+ and CD8+ T cells against cytomegalovirus in very old subjects. J Immunol 179(6):4283–4291
Virelizier JL, Allison AC, Schild GC (1974) Antibody responses to antigenic determinants of influenza virus hemagglutinin. II. Original antigenic sin: a bone marrow-derived lymphocyte memory phenomenon modulated by thymus-derived lymphocytes. J Exp Med 140(6):1571–1578
Wagar LE, Gentleman B, Pircher H et al (2011) Influenza-specific T cells from older people are enriched in the late effector subset and their presence inversely correlates with vaccine response. PLoS One 6(8):e23698
Wenisch C, Patruta S, Daxbock F et al (2000) Effect of age on human neutrophil function. J Leukoc Biol 67(1):40–45
Whitley RJ, Monto AS (2006) Prevention and treatment of influenza in high-risk groups: children, pregnant women, immunocompromised hosts, and nursing home residents. J Infect Dis 194(Suppl 2):S133–S138
Zhou X, McElhaney JE (2011) Age-related changes in memory and effector T cells responding to influenza A/H3N2 and pandemic A/H1N1 strains in humans. Vaccine 29(11):2169–2177
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Moazzami, K., McElhaney, J.E., Rezaei, N. (2014). Influenza Infection in the Elderly. In: Massoud, A., Rezaei, N. (eds) Immunology of Aging. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-39495-9_18
Download citation
DOI: https://doi.org/10.1007/978-3-642-39495-9_18
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-39494-2
Online ISBN: 978-3-642-39495-9
eBook Packages: MedicineMedicine (R0)